DOCTOOLS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.8% 5.2% 5.6% 6.6% 6.7%  
Credit score (0-100)  41 43 39 36 35  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  357 460 1,015 288 220  
EBITDA  101 131 634 74.2 18.8  
EBIT  101 131 634 74.2 18.8  
Pre-tax profit (PTP)  119.4 126.2 648.2 68.8 17.0  
Net earnings  93.1 98.4 505.6 53.6 13.2  
Pre-tax profit without non-rec. items  119 126 648 68.8 17.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  298 296 702 397 210  
Interest-bearing liabilities  10.3 17.9 169 147 150  
Balance sheet total (assets)  402 415 925 608 433  

Net Debt  -278 -208 -448 -446 -273  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  357 460 1,015 288 220  
Gross profit growth  -60.7% 28.9% 120.8% -71.6% -23.6%  
Employees  0 1 0 0 1  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  402 415 925 608 433  
Balance sheet change%  -65.7% 3.1% 123.0% -34.3% -28.7%  
Added value  101.4 130.5 634.1 74.2 18.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  28.4% 28.4% 62.5% 25.7% 8.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.6% 33.3% 97.6% 9.7% 3.8%  
ROI %  21.4% 43.7% 110.3% 10.5% 4.4%  
ROE %  16.9% 33.1% 101.3% 9.8% 4.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  74.1% 71.5% 75.9% 65.3% 48.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -274.2% -159.3% -70.7% -600.9% -1,454.9%  
Gearing %  3.5% 6.0% 24.1% 37.0% 71.7%  
Net interest  0 0 0 0 0  
Financing costs %  15.9% 69.2% 6.0% 3.5% 2.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.9 3.5 4.1 2.9 1.9  
Current Ratio  3.9 3.5 4.1 2.9 1.9  
Cash and cash equivalent  288.3 225.9 617.2 592.4 423.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  297.9 296.4 701.9 396.6 209.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 131 0 0 19  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 131 0 0 19  
EBIT / employee  0 131 0 0 19  
Net earnings / employee  0 98 0 0 13